产业创新生态系统的建设策略：基于浙江生物医药产业的案例研究

Construction Strategy of Industrial Innovation Ecosystem: A Case Study of Zhejiang Bio-pharmaceutical Industry

关键词:  创新生态系统|创新管理|生物医药产业|浙江省

Key words:  innovation ecosystem|innovation management|bio-pharmaceutical industry|Zhejiang province

摘要:

目的 在调查分析浙江生物医药产业的基础上，通过研究生物医药产业创新生态系统模型的构成要素，构建生物医药产业创新生态系统。方法 运用创新生态系统理论，界定生物医药产业创新生态系统的概念和内涵，将自然生态系统的结构和特点对应至生物医药产业，构建相应的模型。以浙江生物医药产业为案例，分析浙江生物医药产业创新生态系统存在的短板，提出建议。结果 创新细化出2条物质流路，即生产者提供的知识、人才不经由消费者，而直接进入分解者和部分含生产功能分解者生产的产品不经由消费者而直接分解。信任是产生协作意识的前提，决定了创新主体投入和贡献的水平，决定了创新主体之间相互协作创新的效率。结论 本研究从创新源头策源能力、核心企业培养、主体信任强化、政府引导支持、服务机构升级、平台扩展等6个方面提出系统建设对策，为推动生物医药产业创新发展提供参考依据。

Abstract:

OBJECTIVE To constructed the bio-pharmaceutical industry innovation ecosystem by studying the components of the bio-pharmaceutical industry innovation ecosystem model on the basis of investigation and analysis of Zhejiang’s bio-pharmaceutical industry. METHODS The concept and connotation of bio-pharmaceutical industrial innovation ecosystem was defined, bio-pharmaceutical industrial innovation ecosystem model was built referring to natural ecosystem by using the theory of innovation ecosystem and mapping the structure and characteristics of natural ecosystem. Via a case study of Zhejiang bio-pharmaceutical industry, weakness of bio-pharmaceutical industrial innovation ecosystem was analyzed and suggestions were proposed. RESULTS Two creative material flowing routes were refined which producer-provided knowledge and talents enter the decomposer while avoiding the consumer and products provided by some decomposers with production function were decomposed while avoiding the consumer. Trust was the premise of generating cooperative consciousness, which determined the level of input and contribution of innovation subjects and the efficiency of collaborative innovation among innovation subjects. CONCLUSION This research puts forward system construction countermeasures from six aspects, the ability of innovation source strategy, core enterprise cultivation, subject trust enhancement, government guidance and support, service organization upgrading, and platform expansion, to provide reference for promoting the innovative development of the bio-pharmaceutical industry.